Credentis Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
Credentis General Information
Description
Developer of oral hygiene products designed to prevent and treat dental diseases. The company's products offer relief for sensitive teeth, protection from acid erosion, teeth brightening and treatment of white spot lesions, providing dental professionals and patients products for tooth regeneration, protection and desensitization.
Contact Information
Website
www.credentis.comCorporate Office
- Dorfstrasse 69
- CH-5210 Windisch
- Switzerland
Corporate Office
- Dorfstrasse 69
- CH-5210 Windisch
- Switzerland
Credentis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 09-Dec-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B) | 11-Mar-2013 | Completed | Generating Revenue | |||
| 5. Grant | 19-Jun-2012 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Angel (individual) | 15-Nov-2011 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 17-Jun-2010 | $217K | $217K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Credentis Patents
Credentis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250082552-A1 | Dental care products comprising stannous flouride | Pending | 11-Sep-2023 | ||
| AU-2024339356-A1 | Dental care products comprising stannous fluoride | Pending | 11-Sep-2023 | ||
| EP-4777069-A1 | Dental care products comprising stannous fluoride | Pending | 11-Sep-2023 | ||
| WO-2025056542-A1 | Dental care products comprising stannous fluoride | Inactive | 11-Sep-2023 | ||
| JP-2026530523-A | Dental care products containing stannous fluoride | Pending | 11-Sep-2023 | A61Q11/00 |
Credentis Signals
Credentis Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aargauische Kantonalbank | Corporation | Minority | ||
| Acceleration International | Growth/Expansion | Minority | ||
| BioBac | Angel Group | Minority | ||
| StartAngels Network | Angel Group | Minority | ||
| Swiss National Science Foundation | Other |
Credentis FAQs
-
When was Credentis founded?
Credentis was founded in 2010.
-
Where is Credentis headquartered?
Credentis is headquartered in Windisch, Switzerland.
-
What is the size of Credentis?
Credentis has 11 total employees.
-
What industry is Credentis in?
Credentis’s primary industry is Pharmaceuticals.
-
Is Credentis a private or public company?
Credentis is a Private company.
-
What is Credentis’s current revenue?
The current revenue for Credentis is .
-
How much funding has Credentis raised over time?
Credentis has raised $4.73M.
-
Who are Credentis’s investors?
Aargauische Kantonalbank, Acceleration International, BioBac, StartAngels Network, and Swiss National Science Foundation are 5 of 8 investors who have invested in Credentis.
-
When was Credentis acquired?
Credentis was acquired on 09-Dec-2020.
-
Who acquired Credentis?
Credentis was acquired by vVardis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process